Amcasertib (BBI503)

Ask supplier a question | View on supplier's website

Amcasertib (BBI503), a first-in-class cancer stemness kinase inhibitor, is claimed to inhibit Nanog and other CSC pathways by targeting kinases with potential anticancer activity.

Supplier	Selleck Chemicals
Product #	S8572
Sku #	S8572-5mg
Pricing	5mg, $347.00

Feedback